Mylan, the maker of the EpiPen, is embroiled in a controversy over the pricing of the allergy-treatment medicine.
The company has increased the price of the drug over 500% since 2007, from a list price of $93.88 to $608.81 today.
In a press release defending its business practices, the company also laid part of the blame at the feet President Barack Obama and the Affordable Care Act, the healthcare law better known as Obamacare.
